|  Help  |  About  |  Contact Us

Publication : PPM1D mutations are oncogenic drivers of de novo diffuse midline glioma formation.

First Author  Khadka P Year  2022
Journal  Nat Commun Volume  13
Issue  1 Pages  604
PubMed ID  35105861 Mgi Jnum  J:320238
Mgi Id  MGI:6870143 Doi  10.1038/s41467-022-28198-8
Citation  Khadka P, et al. (2022) PPM1D mutations are oncogenic drivers of de novo diffuse midline glioma formation. Nat Commun 13(1):604
abstractText  The role of PPM1D mutations in de novo gliomagenesis has not been systematically explored. Here we analyze whole genome sequences of 170 pediatric high-grade gliomas and find that truncating mutations in PPM1D that increase the stability of its phosphatase are clonal driver events in 11% of Diffuse Midline Gliomas (DMGs) and are enriched in primary pontine tumors. Through the development of DMG mouse models, we show that PPM1D mutations potentiate gliomagenesis and that PPM1D phosphatase activity is required for in vivo oncogenesis. Finally, we apply integrative phosphoproteomic and functional genomics assays and find that oncogenic effects of PPM1D truncation converge on regulators of cell cycle, DNA damage response, and p53 pathways, revealing therapeutic vulnerabilities including MDM2 inhibition.
Quick Links:
 
Quick Links:
 

Expression

Publication --> Expression annotations

 

Other

1 Bio Entities

Trail: Publication

0 Expression